These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17022996

  • 1. Antigens for the selection of pan-variable number of tandem repeats motif-specific human antibodies against Mucin-1.
    Persson J, Ohlin M.
    J Immunol Methods; 2006 Oct 20; 316(1-2):116-24. PubMed ID: 17022996
    [Abstract] [Full Text] [Related]

  • 2. Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity.
    Mazor Y, Keydar I, Benhar I.
    Mol Immunol; 2005 Jan 20; 42(1):55-69. PubMed ID: 15488944
    [Abstract] [Full Text] [Related]

  • 3. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ.
    Cancer Res; 1994 Jun 01; 54(11):2856-60. PubMed ID: 7514493
    [Abstract] [Full Text] [Related]

  • 4. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A, Samonskyte L, Gedvilaite A, Voronkova T, Ulrich R, Sasnauskas K.
    J Immunol Methods; 2006 Apr 20; 311(1-2):57-70. PubMed ID: 16516908
    [Abstract] [Full Text] [Related]

  • 5. Subtle sequence differences in a tumour-associated peptide epitope translate into major changes in antigenicity.
    Persson J, Lantto J, Drakenberg T, Ohlin M.
    Mol Immunol; 2005 Jul 20; 42(11):1321-30. PubMed ID: 15950728
    [Abstract] [Full Text] [Related]

  • 6. Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules.
    Burke PA, Gregg JP, Bakhtiar B, Beckett LA, Denardo GL, Albrecht H, De Vere White RW, De Nardo SJ.
    Int J Oncol; 2006 Jul 20; 29(1):49-55. PubMed ID: 16773184
    [Abstract] [Full Text] [Related]

  • 7. Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.
    Zhang S, Zhang H, Shi H, Yu X, Kong W, Li W.
    Hum Immunol; 2008 Jul 20; 69(4-5):250-8. PubMed ID: 18486759
    [Abstract] [Full Text] [Related]

  • 8. Mapping of the 45M1 epitope to the C-terminal cysteine-rich part of the human MUC5AC mucin.
    Lidell ME, Bara J, Hansson GC.
    FEBS J; 2008 Feb 20; 275(3):481-9. PubMed ID: 18167142
    [Abstract] [Full Text] [Related]

  • 9. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
    Karsten U, Serttas N, Paulsen H, Danielczyk A, Goletz S.
    Glycobiology; 2004 Aug 20; 14(8):681-92. PubMed ID: 15115750
    [Abstract] [Full Text] [Related]

  • 10. Heritable variation in expression of multiple tumor associated epitopes on a high molecular weight mucin-like antigen.
    Linsley PS, Ochs V, Horn D, Ring DB, Frankel AE.
    Cancer Res; 1986 Dec 20; 46(12 Pt 1):6380-6. PubMed ID: 2430697
    [Abstract] [Full Text] [Related]

  • 11. Screening for a human single chain Fv antibody against epitope on amyloid-beta 1-40 from a human phage display library.
    Zhao ZF, Gao GQ, Liu S, Zou JT, Xie Y, Yuan QF, Wang HQ, Yao ZB.
    Chin Med J (Engl); 2007 Nov 05; 120(21):1931-4. PubMed ID: 18067770
    [No Abstract] [Full Text] [Related]

  • 12. Cellular Mucins: Targets for Immunotherapy.
    Apostolopoulos V, McKenzie IFC.
    Crit Rev Immunol; 2017 Nov 05; 37(2-6):421-437. PubMed ID: 29773028
    [Abstract] [Full Text] [Related]

  • 13. The contribution of tandem repeat number to the O-glycosylation of mucins.
    Silverman HS, Sutton-Smith M, McDermott K, Heal P, Leir SH, Morris HR, Hollingsworth MA, Dell A, Harris A.
    Glycobiology; 2003 Apr 05; 13(4):265-77. PubMed ID: 12626424
    [Abstract] [Full Text] [Related]

  • 14. Anti-mucin monoclonal antibodies.
    Xing PX, Apostolopoulos V, Pietersz G, McKenzie IF.
    Front Biosci; 2001 Oct 01; 6():D1284-95. PubMed ID: 11578979
    [Abstract] [Full Text] [Related]

  • 15. Humanization of an anti-mucin antibody for breast and ovarian cancer therapy.
    Baker TS, Bose CC, Caskey-Finney HM, King DJ, Lawson AD, Lyons A, Mountain A, Owens RJ, Rolfe MR, Sehdev M.
    Adv Exp Med Biol; 1994 Oct 01; 353():61-82. PubMed ID: 7985543
    [Abstract] [Full Text] [Related]

  • 16. Peptide epitopes in breast cancer mucins.
    Xing PX, Apostolopoulos V, Trapani J, Prenzoska J, McKenzie IF.
    Adv Exp Med Biol; 1994 Oct 01; 353():9-16. PubMed ID: 7527180
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3.
    Couto JR, Blank EW, Peterson JA, Kiwan R, Padlan EA, Ceriani RL.
    Adv Exp Med Biol; 1994 Oct 01; 353():55-9. PubMed ID: 7985542
    [No Abstract] [Full Text] [Related]

  • 19. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage.
    Bowley DR, Labrijn AF, Zwick MB, Burton DR.
    Protein Eng Des Sel; 2007 Feb 01; 20(2):81-90. PubMed ID: 17242026
    [Abstract] [Full Text] [Related]

  • 20. Recombinant breast carcinoma-associated mucins expressed in a baculovirus system contain a tumor specific epitope.
    Hu P, Wright SE.
    Immunotechnology; 1998 Oct 01; 4(2):97-105. PubMed ID: 9853951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.